This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
13 Oct 2010

FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures

The FDA warns that the Precautions section of the labels of all bisphosphonate drugs approved for the prevention or treatment of osteoporosis.

Related News